Capital Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 10.76%
(FY 2022)
- Ebitda 64.77%
(FY 2022)
- Net Worth 66.12%
(FY 2022)
- Total Assets 1.66%
(FY 2022)
About Capital Pharmaceuticals
The Corporate was formerly known as Babu Fancy Breweries Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohanbhai Patel, Bhartiben Patel, and Chirag Patel serve as directors at the Company.
- CIN/LLPIN
U24232DD2011PTC004693
- Company No.
004693
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
Daman, Daman & Diu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Capital Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohanbhai Patel  | Director | 11-Mar-2011 | Current |
| Bhartiben Patel | Director | 11-Mar-2011 | Current |
| Chirag Patel | Director | 11-Mar-2011 | Current |
Financial Performance of Capital Pharmaceuticals.
Capital Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 10.76% increase in profit. The company's net worth Soared by an impressive increase of 66.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Capital Pharmaceuticals?
In 2018, Capital Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Capital Pharmaceuticals?
Unlock and access historical data on people associated with Capital Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Capital Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Capital Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
